RFK Jr. has been named the top health official in Trump's administration, and he's known for his stance against big pharma and preference for natural products like psychedelics. This could be a game-changer for psychedelic stocks!
In this video analysis, I dive deep into the potential impact RFK Jr. could have on key psychedelic stocks: CYBN, CMPS, ATAI, and MNMD.
These stocks are poised for significant movement, and you won't want to miss out on the insights and strategies I share. Not financial advice. 👇